Across TCGA pan-cancer cohorts, HNRNPA1P1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of HNRNPA1P1’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where HNRNPA1P1 RNA is repressed in tumor relative to normal tissue. In most cancer types HNRNPA1P1 is over-expressed in tumor, although a few such as PAAD show the opposite, repressed pattern.

PAAD, COAD, and LIHC are the cancer types where HNRNPA1P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in HNRNPA1P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PAAD	Female	All	−0.205	.044	2	view →
COAD	All	II,III,IV	+0.090	.016	2	view →
LIHC	All	All	+0.010	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: HNRNPA1P1 RNA expression & survival · all HNRNPA1P1 data types